About the Authors
- Marcel Prothmann
-
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty of the Humboldt University of Berlin and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany
- Florian von Knobelsdorff-Brenkenhoff
-
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty of the Humboldt University of Berlin and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany
- Agnieszka Töpper
-
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty of the Humboldt University of Berlin and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany
- Matthias A. Dieringer
-
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty of the Humboldt University of Berlin and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany
- Etham Shahid
-
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty of the Humboldt University of Berlin and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany
- Andreas Graessl
-
Affiliation Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany
- Jan Rieger
-
Affiliation MRI.TOOLS GmbH, Berlin, Germany
- Darius Lysiak
-
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, MRI.TOOLS GmbH, Berlin, Germany
- C. Thalhammer
-
Affiliation Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany
- Till Huelnhagen
-
Affiliation Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany
- Peter Kellman
-
Affiliation National Institutes of Health / NHLBI, Bethesda, Maryland, United States of America
- Thoralf Niendorf
-
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, MRI.TOOLS GmbH, Berlin, Germany, DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany
- Jeanette Schulz-Menger
-
* E-mail: Jeanette.Schulz-Menger@charite.de
Affiliations Berlin Ultrahigh Field Facility (B.U.F.F.), Max-Delbrueck Center for Molecular Medicine, Berlin, Germany, Working Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty of the Humboldt University of Berlin and the Max-Delbrueck Center for Molecular Medicine, and HELIOS Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany, DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany
Competing Interests
Thoralf Niendorf is founder and CEO of MRI.TOOLS GmbH, Berlin, Germany. Jan Rieger is founder and CTO of MRI.TOOLS GmbH, Berlin, Germany. Darius Lysiak is currently an employee of MRI.TOOLS GmbH, Berlin, Germany. Thoralf Niendorf, Jan Rieger and Darius Lysiak from MRI.TOOLS GmbH provided the easyACT (an acoustic a triggering/gating device) together with the RF coil array used in this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: JSM MP. Performed the experiments: JSM MP AT FvK. Analyzed the data: MP ES FvK JSM. Contributed reagents/materials/analysis tools: TN PK CT TH MD AG DL JR. Wrote the paper: MP JSM TN.